+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Protection studies in a mouse burn wound sepsis model with a human anti pseudomonas aeruginosa flagella monoclonal antibody and its fab 2 and fab fragments



Protection studies in a mouse burn wound sepsis model with a human anti pseudomonas aeruginosa flagella monoclonal antibody and its fab 2 and fab fragments



Abstracts of the Annual Meeting of the American Society for Microbiology 90: 123




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033003606

Download citation: RISBibTeXText


Related references

Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model. Burns 35(3): 390-396, 2009

Immunoprophylaxis of pseudomonas aeruginosa burn wound sepsis with a cross reactive human monoclonal antibody. Abstracts of the Annual Meeting of the American Society for Microbiology 88: 126, 1988

Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide. Infection and Immunity 39(3): 1072-1079, 1983

Silver sulfadiazine anti infect burn sepsis pseudomonas aeruginosa mouse human. Modern Treatment 4(6): 1259-1262, 1967

Negative pressure wound therapy decreases mortality in a murine model of burn-wound sepsis involving Pseudomonas aeruginosa infection. Plos one 9(2): E90494, 2014

Protection of mice against lethal pseudomonas aeruginosa infection with murine anti flagella monoclonal antibodies. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 136, 1989

Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide. Infection and Immunity 43(3): 795-799, 1984

The establishment of a Pseudomonas aeruginosa-infected burn-wound sepsis model and the effect of imipenem treatment. Annals of Plastic Surgery 56(6): 674-679, 2006

Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis. Burns 37(5): 865-872, 2011

Protection against pseudomonas aeruginosa pa sepsis in burned mice with cross reactive monoclonal antibody mca. Abstracts of the Annual Meeting of the American Society for Microbiology 88: 49, 1988

Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection. Journal of Antimicrobial ChemoTherapy 66(5): 1100-1109, 2011

Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model. Immunology Letters 176: 8, 2016

Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrobial Agents and ChemoTherapy 51(6): 1934-1938, 2007

Immunogenicity of Pseudomonas aeruginosa recombinant b-type fagellin as a vaccine candidate: Protective efficacy in a murine burn wound sepsis model. Burns 2016:, 2016

Anti flagellin B antibodies in Pseudomonas aeruginosa murine infected burn wound model. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 43: 66, 2003